Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H25Cl2FN4O2 |
| Molecular Weight | 491.385 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](COC3=CC4=NC=NC(NC5=C(F)C(Cl)=C(Cl)C=C5)=C4C=C3OC)C[C@]1([H])CN(C)C2
InChI
InChIKey=HVXKQKFEHMGHSL-QKDCVEJESA-N
InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+
| Molecular Formula | C24H25Cl2FN4O2 |
| Molecular Weight | 491.385 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:09:33 UTC 2023
by
admin
on
Sat Dec 16 02:09:33 UTC 2023
|
| Record UNII |
F6XM2TN5A1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1967
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
||
|
FDA ORPHAN DRUG |
802420
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
||
|
NCI_THESAURUS |
C1742
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
||
|
NCI_THESAURUS |
C129825
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
||
|
FDA ORPHAN DRUG |
506715
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
||
|
FDA ORPHAN DRUG |
584917
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BC-18
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
10079
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
Tesevatinib
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
C62496
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
10458325
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
DTXSID201336925
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
F6XM2TN5A1
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
CHEMBL3544983
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
167674
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
300000034419
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
781613-23-8
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY | |||
|
DB11973
Created by
admin on Sat Dec 16 02:09:33 UTC 2023 , Edited by admin on Sat Dec 16 02:09:33 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
